This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
₹2.15
Share price
0.00%
Change (1 day)
-99.25%
Change (1 year)
Categories
ViewRay (VRAY) - Net assets
Net assets on the balance sheet as of March 2023 : ₹4.75 Billion
According to ViewRay's latest financial reports the company has ₹4.75 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ViewRay - Net assets on balance sheet (from 2014 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $₹6.80 B | -46.15% |
| 2021-12-31 | $₹12.63 B | 32.66% |
| 2020-12-31 | $₹9.52 B | -38.2% |
| 2019-12-31 | $₹15.41 B | 31.77% |
| 2018-12-31 | $₹11.69 B | 9120.87% |
| 2017-12-31 | $₹0.12 B | -104.28% |
| 2016-12-31 | $-₹2.97 Billion | 541.63% |
| 2015-12-31 | $-₹0.47 Billion | |
| 2014-11-30 | $₹0.19 M | 4.24% |
| 2013-11-30 | $₹0.18 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | ₹4.75 B | 0.00% | 🇺🇸 USA |
 | ₹47.68 B | 902.95% | 🇺🇸 USA |
 | ₹14.10 B | 196.59% | 🇮🇱 Israel |